IVERIC bio (FRA:O2T) Long-Term Capital Lease Obligation : €0.00 Mil (As of Mar. 2023)

View and export this data going back to 2013. Start your Free Trial

What is IVERIC bio Long-Term Capital Lease Obligation?

IVERIC bio's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2023 was €0.00 Mil.

IVERIC bio's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 (€0.03 Mil) to Dec. 2022 (€0.01 Mil) and declined from Dec. 2022 (€0.01 Mil) to Mar. 2023 (€0.00 Mil).

IVERIC bio's annual Long-Term Capital Lease Obligation increased from Dec. 2020 (€0.05 Mil) to Dec. 2021 (€0.55 Mil) but then declined from Dec. 2021 (€0.55 Mil) to Dec. 2022 (€0.01 Mil).

IVERIC bio Long-Term Capital Lease Obligation Historical Data

The historical data trend for IVERIC bio's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVERIC bio Long-Term Capital Lease Obligation Chart

IVERIC bio Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.05

0.55

0.01

IVERIC bio Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.35	0.31	0.03	0.01	-

IVERIC bio (FRA:O2T) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

IVERIC bio Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of IVERIC bio's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

IVERIC bio (FRA:O2T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IVERIC bio Inc (FRA:O2T) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Sylvan Way, Parsippany, New Jersey, USA, 07054

Website

https://www.ivericbio.com

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

IVERIC bio (FRA:O2T) Headlines

No Headlines